Basic Information
| LncRNA/CircRNA Name | ASlnc07322 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | RT-PCR, ChIP-PCR |
| Sample | colon cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | ASLNC07322 knockdown combined with Smad4 overexpression could efficiently inhibit lymphatic endothelial cells (LECs) proliferation and tube formation in vitro, as well as tumor growth and lymphangiogenesis in vivo. |
| Pubmed ID | 31739210 |
| Year | 2019 |
| Title | Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis |
External Links
| Links for ASlnc07322 | GenBank HGNC NONCODE |
| Links for colon cancer | OMIM COSMIC |